Epana Bio is pioneering precision therapies for autoimmune diseases by targeting root cellular dysfunction. Leveraging genomics and AI-driven systems immunology, the company designs bespoke biologics tailored to each patient’s unique immune profile. With a nimble, science-first team, it is on a mission to redefine autoimmune care and improve outcomes for individuals often underserved by one-size-fits-all treatments.